TÖÖ & TERVIS OÜ

Active Registry code 10962668 OÜ Haapsalu linn Registered 19 Aug 2003

TÖÖ & TERVIS OÜ is a OÜ based in Haapsalu linn, registry code 10962668, status: active. Main activity: Medical specialists activities. Its annual report for 2025 shows revenue of €37 487 and 1 employees.

Turnover

—

State taxes

1 657 €

↑ 0.8% vs Q2 2026

Labour taxes

1 721 €

↑ 0.0% vs Q2 2026

Employees

±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

Labour taxes per employee 1 721 €

above 41% of companies

industry median 2 177 € · companies in the industry: 1 696
Revenue · 2025 37 487 €

above 60% of companies

industry median 20 811 € · companies in the industry: 3 373
Net profit margin · 2025 30.4 %

above 78% of companies

industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q4 2023 – Q3 2026

Labour taxes per employee, € Q3 2026: 1 721 € · +0.0% vs Q2 2026 · industry median 2 177 € · above 41% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 1 · +0.0% vs Q2 2026

State taxes, € Q3 2026: 1 657 € · +0.8% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	—	1 657	1 721	1
Q2 2026	—	1 644	1 721	1
Q1 2026	—	2 088	2 178	1
Q4 2025	—	1 662	1 721	1
Q3 2025	—	1 637	1 721	1
Q2 2025	—	1 662	1 721	1
Q1 2025	—	1 617	1 701	1
Q4 2024	—	1 578	1 662	1
Q3 2024	—	1 578	1 662	1
Q2 2024	—	1 578	1 662	1
Q1 2024	—	2 104	2 216	1
Q4 2023	—	1 578	1 662	1
Q3 2023	—	1 578	1 662	1
Q2 2023	—	1 578	1 662	1
Q1 2023	—	1 578	1 662	1
Q4 2022	—	1 676	1 766	1
Q3 2022	—	1 578	1 662	3
Q2 2022	—	1 368	1 440	3
Q1 2022	—	1 262	1 330	3

Labour taxes per employee per month

574 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € 2025: 37 487 € · +37.0% vs 2024 · industry median 20 811 € · above 60% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 11 383 € · +17 147.0% vs 2024 · industry median 1 071 € · above 70% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 30.4 % · +30.1 pp vs the year before · industry median 8.3 % · above 78% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 66 697 € · +20.5% vs 2024

Equity, € 2025: 60 928 € · +23.0% vs 2024

Employees 2025: 1 · +0.0% vs 2024 · industry median 2 · above 5% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	37 487	11 383	17 153	66 697	60 928	1
2024	27 368	66	16 056	55 359	49 545	1
2023	26 435	-1 445	17 394	54 141	49 479	1
2022	27 181	15 591	15 237	54 011	48 965	1
2021	24 694	-1 490	9 933	38 039	33 374	1
2020	22 272	-4 185	11 758	83 590	49 864	2
2019	34 208	-1 499	13 385	87 862	54 049	2
2018	—	—	—	—	—	2
2017	—	—	—	—	—	2
2016	—	—	—	—	—	2
2015	—	—	—	—	—	2
2014	—	—	—	—	—	2
2013	—	—	—	—	—	2
2012	—	—	—	—	—	3
2011	—	—	—	—	—	2
2010	—	—	—	—	—	2
2009	—	—	—	—	—	2
2008	—	—	—	—	—	2
2007	—	—	—	—	—	2
2006	—	—	—	—	—	1
2005	—	—	—	—	—	2
2004	—	—	—	—	—	2

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

30.4 %

Net profit / revenue

Return on equity (ROE)

18.7 %

Net profit / equity

Return on assets (ROA)

17.1 %

Net profit / assets

Equity ratio

91.4 %

Equity / assets

Debt ratio

8.6 %

Liabilities / assets

Current ratio

6.92

Current assets / current liabilities

Revenue per employee

37 487 €

Revenue / average full-time employees

Labour cost per employee per month

1 429 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	31 Jul 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	31 Jul 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	31 Jul 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	25 Aug 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	11 Oct 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	18 Aug 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	15 Dec 2020	Company’s own	e-Äriregister

Board

Silver Saarik
Board member · since 2 Jan 2006

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Silver Saarik
Natural person · 40 000 €

100%

Beneficial owners

No beneficial owners listed.

Founders and other persons

Silver Saarik
Founder · 40 000 € · 19 Aug 2003

Activities (EMTAK)

86221Medical specialists activities Main

Rulings 9

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 30025179 / M1 6 Jul 2024	Warning of deletion from the register: annual report not filed	9 Oct 2024	Deficiencies eliminated 1 Aug 2024	PDF
Ä 30025179 / 7 1 Sep 2023	Amendment entry		In force 1 Sep 2023	PDF
Ä 30025179 / 6 18 Jan 2018	Amendment entry		In force 18 Jan 2018	PDF
Ä 30025179 / 5 23 Dec 2017	Amendment entry		In force 23 Dec 2017	PDF
Ä 30025179 / 4 4 Dec 2017	Amendment entry		In force 4 Dec 2017	PDF
Ä 30025179 / 3 9 Jul 2010	Deletion of activities from the registry card		In force 9 Jul 2010	PDF
Ä 73956 / 2 2 Jan 2006	Change of registry district		Confirmed 2 Jan 2006	PDF
Ä 25179 2 Jan 2006	Change of registry district		Confirmed 2 Jan 2006	PDF
Ä 73956 15 Aug 2003	First entry		In force	PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data